Tagged With AbbVie

Dispensed: Pharma's next big megamerger, a string of healthcare IPOs, and why the CEO of Clover Health regrets setting up shop in Silicon Valley


Allergan spikes 30% after AbbVie agrees to buy the Botox-maker for $63 billion


Abbvie is buying Allergan in a $63 billion pharma mega-deal



A cancer drug that AbbVie acquired in a $10 billion deal is looking more and more like a failure


A company that's taking a new approach to tackling Alzheimer's is moving into human trials after raising $133 million


A new treatment for a condition that can feel like tiny people skating on razor blades in your stomach and affects an estimated 200 million women just got approved



Allergan started out as a tiny but beloved Southern California eye care firm before expanding to a $130 billion company. Here's how the Botox-maker fell out grace with investors and then became a takeover target.


A company that's taking a new approach to tackling Alzheimer's just landed a $225 million endorsement


'Nobody's talking about' 2 medical conditions that affect 8 million women in America -- but that could be about to change


Here's the cancer data that led AbbVie to make the second-largest acquisition in the history of venture capital


Here's why pharma giant AbbVie coughed up $10 billion to buy a startup you've never heard of


The FDA just approved a new cancer drug -- here's what you need to know about it



Here's what the future of cancer treatment looks like


The FDA just approved an immune-system-stimulating blood cancer drug


Drugmaker AbbVie's stock gets slammed after FDA warning


Wall Street's best bankers keep leaving the industry